BioCentury
ARTICLE | Company News

Apricus, Ferring deal

March 17, 2017 6:50 PM UTC

Apricus sold to Ferring remaining ex-U.S. rights and assets related to erectile dysfunction drug Vitaros alprostadil for $11.5 million upfront, plus up to $700,000 for product inventory and up to $500,000 for transition assistance. Ferring had exclusive commercialization rights to Vitaros in Latin America and the Caribbean under a 2015 deal, which was later expanded to include parts of Europe and Asia...